Evaluation of Proclarix in the diagnostic work‐up of prostate cancer

Evaluation of Proclarix in the diagnostic work‐up of prostate cancer

Abstract Objectives The use of multiparametric magnetic resonance imaging (mpMRI) has been widely adopted in the diagnostic work‐up for suspicious prostate cancer (PCa) and is recommended in most current guidelines. However, mpMRI lesions are often indeterminate and/or turn out to be false‐positive...

Full description

Bibliographic Details
Main Authors: Basil Kaufmann, Sharon Fischer, Alcibiade Athanasiou, Noémie Lautenbach, Anja Wittig, Uwe Bieri, Florian A. Schmid, Franz vonStauffenberg, Thomas Scherer, Daniel Eberli, Michael A. Gorin, Ralph Schiess, Cédric Poyet
Format: Article
Language:English
Published: Wiley 2024-02-01
Series:BJUI Compass
Subjects:
biomarkers
biopsy
cathepsin D, CTSD
Proclarix
prostate cancer
thrombospondin 1, THBS1
Online Access:https://doi.org/10.1002/bco2.293

Internet

https://doi.org/10.1002/bco2.293

Similar Items